Author

Michio Ozeki

Institutions: Nagoya Medical Center, Gifu University, Center for One Medicine Innovative Translational Research

Observed institutions: Nagoya Medical Center, Gifu University, Center for One Medicine Innovative Translational Research

ORCID: 0009-0003-0224-4201

Observed ORCID: 0009-0003-0224-4201

OpenAlex ID: A5007426709

Sirolimus treatment for intractable vascular anomalies ( SIVA ): An open‐label, single‐arm, multicenter, prospective trial

2025 · Michio Ozeki, Saori Endo, et al. · Pediatrics International · 9

Comparative Analysis of Plasma MicroRNAs in Patients With Kaposiform Hemangioendothelioma and Tufted Angioma Versus Infantile Hemangioma

2025 · Akifumi Nozawa, Michio Ozeki, et al. · Journal of Pediatric Hematology/Oncology · 1

Sirolimus for Recurrent Chylothorax and Edema in an Infant with Noonan Syndrome after Resolved Hydrops Fetalis: A Case Report

2025 · Mariko Hattori, Kei Tamai, et al. · American Journal of Perinatology Reports · 1

Works count: 3

Citation count: 11

H-index: 1

I10-index: